586 related articles for article (PubMed ID: 15589338)
1. Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression.
Szapacs ME; Mathews TA; Tessarollo L; Ernest Lyons W; Mamounas LA; Andrews AM
J Neurosci Methods; 2004 Dec; 140(1-2):81-92. PubMed ID: 15589338
[TBL] [Abstract][Full Text] [Related]
2. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression.
Mathews TA; Fedele DE; Coppelli FM; Avila AM; Murphy DL; Andrews AM
J Neurosci Methods; 2004 Dec; 140(1-2):169-81. PubMed ID: 15589347
[TBL] [Abstract][Full Text] [Related]
3. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
[TBL] [Abstract][Full Text] [Related]
4. Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice.
Ren-Patterson RF; Cochran LW; Holmes A; Sherrill S; Huang SJ; Tolliver T; Lesch KP; Lu B; Murphy DL
J Neurosci Res; 2005 Mar; 79(6):756-71. PubMed ID: 15672416
[TBL] [Abstract][Full Text] [Related]
5. Reduced brain-derived neurotrophic factor is associated with a loss of serotonergic innervation in the hippocampus of aging mice.
Luellen BA; Bianco LE; Schneider LM; Andrews AM
Genes Brain Behav; 2007 Jul; 6(5):482-90. PubMed ID: 17156118
[TBL] [Abstract][Full Text] [Related]
6. Effects of brain-derived neurotrophic factor (BDNF) on glial cells and serotonergic neurones during development.
Djalali S; Höltje M; Grosse G; Rothe T; Stroh T; Grosse J; Deng DR; Hellweg R; Grantyn R; Hörtnagl H; Ahnert-Hilger G
J Neurochem; 2005 Feb; 92(3):616-27. PubMed ID: 15659231
[TBL] [Abstract][Full Text] [Related]
7. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
Wang X; Baumann MH; Xu H; Rothman RB
Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
[TBL] [Abstract][Full Text] [Related]
8. Influence of brain-derived neurotrophic factor (BDNF) on serotonin neurotransmission in the hippocampus of adult rodents.
Benmansour S; Deltheil T; Piotrowski J; Nicolas L; Reperant C; Gardier AM; Frazer A; David DJ
Eur J Pharmacol; 2008 Jun; 587(1-3):90-8. PubMed ID: 18474368
[TBL] [Abstract][Full Text] [Related]
9. Substituted amphetamines that produce long-term serotonin depletion in rat brain ("neurotoxicity") do not decrease serotonin transporter protein expression.
Rothman RB; Jayanthi S; Cadet JL; Wang X; Dersch CM; Baumann MH
Ann N Y Acad Sci; 2004 Oct; 1025():151-61. PubMed ID: 15542713
[TBL] [Abstract][Full Text] [Related]
10. Mice with reduced brain-derived neurotrophic factor expression show decreased choline acetyltransferase activity, but regular brain monoamine levels and unaltered emotional behavior.
Chourbaji S; Hellweg R; Brandis D; Zörner B; Zacher C; Lang UE; Henn FA; Hörtnagl H; Gass P
Brain Res Mol Brain Res; 2004 Feb; 121(1-2):28-36. PubMed ID: 14969734
[TBL] [Abstract][Full Text] [Related]
11. Dietary restriction changes behaviours in brain-derived neurotrophic factor heterozygous mice: role of serotonergic system.
Koizumi H; Hashimoto K; Iyo M
Eur J Neurosci; 2006 Oct; 24(8):2335-44. PubMed ID: 17074054
[TBL] [Abstract][Full Text] [Related]
12. Consequences of changes in BDNF levels on serotonin neurotransmission, 5-HT transporter expression and function: studies in adult mice hippocampus.
Deltheil T; Guiard BP; Guilloux JP; Nicolas L; Deloménie C; Repérant C; Le Maitre E; Leroux-Nicollet I; Benmansour S; Coudoré F; David DJ; Gardier AM
Pharmacol Biochem Behav; 2008 Aug; 90(2):174-83. PubMed ID: 17980409
[TBL] [Abstract][Full Text] [Related]
13. Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex, of the rat.
Jacobsen JP; Mørk A
Brain Res; 2006 Sep; 1110(1):221-5. PubMed ID: 16876769
[TBL] [Abstract][Full Text] [Related]
14. Isoflurane decreases extracellular serotonin in the mouse hippocampus.
Whittington RA; Virág L
Anesth Analg; 2006 Jul; 103(1):92-8, table of contents. PubMed ID: 16790633
[TBL] [Abstract][Full Text] [Related]
15. Reduced function of the serotonin transporter is associated with decreased expression of BDNF in rodents as well as in humans.
Molteni R; Cattaneo A; Calabrese F; Macchi F; Olivier JD; Racagni G; Ellenbroek BA; Gennarelli M; Riva MA
Neurobiol Dis; 2010 Mar; 37(3):747-55. PubMed ID: 20034565
[TBL] [Abstract][Full Text] [Related]
16. High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain.
Rothman RB; Jayanthi S; Wang X; Dersch CM; Cadet JL; Prisinzano T; Rice KC; Baumann MH
Synapse; 2003 Dec; 50(3):233-9. PubMed ID: 14515341
[TBL] [Abstract][Full Text] [Related]
17. Brain-derived neurotrophic factor expression is increased in the hippocampus of 5-HT(2C) receptor knockout mice.
Hill RA; Murray SS; Halley PG; Binder MD; Martin SJ; van den Buuse M
Hippocampus; 2011 Apr; 21(4):434-45. PubMed ID: 20087884
[TBL] [Abstract][Full Text] [Related]
18. Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areas.
Hellweg R; Zueger M; Fink K; Hörtnagl H; Gass P
Neurobiol Dis; 2007 Jan; 25(1):1-7. PubMed ID: 16990008
[TBL] [Abstract][Full Text] [Related]
19. Late onset loss of hippocampal 5-HT and NE is accompanied by increases in BDNF protein expression in mice co-expressing mutant APP and PS1.
Szapacs ME; Numis AL; Andrews AM
Neurobiol Dis; 2004 Aug; 16(3):572-80. PubMed ID: 15262269
[TBL] [Abstract][Full Text] [Related]
20. The neurotoxin 2'-NH2-MPTP degenerates serotonin axons and evokes increases in hippocampal BDNF.
Luellen BA; Szapacs ME; Materese CK; Andrews AM
Neuropharmacology; 2006 Mar; 50(3):297-308. PubMed ID: 16288930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
